Axumin Pet Scan Indications

Axumin fluciclovine f 18 injection for intravenous use initial u s.

Axumin pet scan indications. 2016 indications and usage axumin is a radioactive diagnostic agent indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence. A negative image does not rule out recurrent. It is the first fda approved f 18 labeled pet scan agent indicated in patients with suspected recurrent prostate. Each milliliter contains up to 2 micrograms of fluciclovine 335 to 8200 mbq 9 to 221 mci fluciclovine f 18 at calibration time and date and 20 mg trisodium citrate in water for injection.

1 psa 1. This has some major limitations for prostate imaging such as bladder interference and a reliance on physical changes within the body to. Image interpretation errors can occur with axumin pet imaging. Axumin fluciclovine f 18 injection is indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen psa levels following prior treatment.

The beauty of the axumin pet scan is that it offers the possibility of detecting small metastatic lesions in the lymph nodes with psa levels in the 1 to 10 range. Hcpcs code g0235 is to be billed for non covered indications. Image interpretation errors can occur with axumin pet imaging. Indicated for positron emission tomography pet.

Effective january 1 2008 hcpcs code a4641 is not applicable for pet scans. Positron emission tomography scans coverage a54666 cpt hcpcs codes group 1 paragraph. Axumin fluciclovine f 18 injection is indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen psa levels following prior treatment. Had little choice but to use 18 fdg to perform the majority of pet ct imaging.

Axumin is a novel molecular imaging agent indicated for use in pet imaging to identify suspected sites of prostate cancer recurrence in men who have elevated blood levels of prostate specific antigen psa following prior treatment. F 18 fluciclovine is indicated for positron emission tomography pet imaging in male patients with suspected prostate cancer recurrence based on elevated prostate specific antigen psa levels following prior treatment. Axumin is a sterile non pyrogenic clear colorless hyperosmolal approximately 500 540 mosm kg injection for intravenous use. Axumin 18 fluciclovine is a radiopharmaceutical that is proving to be a game changer particularly in the field of prostate cancer detection previously clinicians in the u s.

Typical total scan time is 20 30 minutes. Cpt code 78609 is a non covered service effective january 28 2005. Axumin is a radioactive drug and should be handled with appropriate safety measures to minimize radiation exposure during administration. A negative image does not rule out recurrent.